Catherine Skari

A Novel, Effective, and Efficient Strategy for Treating Sickle Cell Vaso-occlusive Events in the Infusion Center Setting

Coagulation factors are proteins in our blood, and they help form blood clots to stop bleeding when is needed. There…

Read More »

Splenectomy in Sickle Cell Disease: Do Benefits Outweigh Risks?

Spleen is an organ in the abdomen that plays an important role in immune system being a key-role organ in…

Read More »

NEW REVIEW | Treatment Landscape of Rare Anaemias Is Shifting Rapidly

Writing in Frontiers in Medicine, the authors began by reviewing congenital and acquired forms of anaemia. Those include sickle cell disease…

Read More »

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major

We assessed the prognostic value of multiparametric cardiovascular magnetic resonance (CMR) in predicting death from heart failure (HF) in thalassemia…

Read More »

A Novel, Effective, and Efficient Strategy for Treating Sickle Cell Vaso-occlusive Events in the Infusion Center Setting

A hypercoagulable state, chronic inflammation, and increased risk of venous thrombosis and stroke are prominent features in patients with sickle…

Read More »

Survival Without Complications Continues to Improve for β-Thalassaemia

New data from a large group of patients with thalassaemia major in Italy, born between 1970 and 1997 and followed…

Read More »

New Molecular Method For The Prenatal Diagnosis Of Thalassemia Under Investigation

A new molecular testing method for the prenatal diagnosis of α- and β-thalassaemia is under investigation. This method may potentially…

Read More »

TOP STORY | EU Approves Luspatercept for Anemia in Patients with Non–Transfusion-Dependent β-Thalassaemia

The approval was based on findings from the phase 2 BEYOND trial, which demonstrated that 77.1% of patients treated with…

Read More »

EMERGENCY APPEAL | TIF Rallies to Provide Earthquake Relief in Turkey and Syria

Among these people, the Thalassaemia International Federation (TIF) estimates that at least 2,000 patients with thalassaemia have been affected, 70%…

Read More »

TIF2023 | The Top International Conference On Thalassaemia Returns This November

The Conference, jointly organised by TIF, the Malaysian Haematology Society, and the Federation of Malaysia Thalassaemia Societies, will feature two…

Read More »